Next Generation of Weight Management Medications: Implications for Diabetes and CVD Risk
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Next Generation of Weight Management Medications: Implications for Diabetes and CVD Risk
Authors
Keywords
Weight management, Medications, Cardiometabolic risks
Journal
Current Cardiology Reports
Volume 17, Issue 5, Pages -
Publisher
Springer Nature
Online
2015-04-17
DOI
10.1007/s11886-015-0590-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Benefit-Risk Assessment of Orlistat in the Treatment of Obesity
- (2014) Priya Sumithran et al. DRUG SAFETY
- Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies
- (2014) V Margaret Jackson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The New Weight-Loss Drugs, Lorcaserin and Phentermine-Topiramate
- (2014) Steven Woloshin et al. JAMA Internal Medicine
- Pharmacotherapy for obesity: novel agents and paradigms
- (2014) Sean Manning et al. Therapeutic Advances in Chronic Disease
- Reducing the Risk of Developing Diabetes
- (2013) Thomas Ransom et al. Canadian Journal of Diabetes
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Recent advancements in drug treatment of obesity
- (2013) R. Carter et al. CLINICAL MEDICINE
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Cardiovascular disease in childhood: the role of obesity
- (2013) Despina Herouvi et al. EUROPEAN JOURNAL OF PEDIATRICS
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Long-term Drug Treatment for Obesity
- (2013) Susan Z. Yanovski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- New and Emerging Drug Molecules Against Obesity
- (2013) Melvin George et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- New pharmacological approaches for obesity management
- (2013) Christian F. Rueda-Clausen et al. Nature Reviews Endocrinology
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs
- (2013) E. W. Chan et al. Obesity Reviews
- Do we need anti-obesity drugs?
- (2012) Vojtěch Hainer et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies
- (2011) Steven P Marso et al. Diabetes & Vascular Disease Research
- Novel strategy for the use of leptin for obesity therapy
- (2011) Charmaine S Tam et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- New approaches to the pharmacological treatment of obesity: Can they break through the efficacy barrier?
- (2010) G.A. Kennett et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
- (2008) M. Nauck et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search